Arca Biopharma | ABIO - Current Assets

Arca Biopharma reported $54.42M in Current Assets for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Assets Change
Amgen AMGN:US USD 22.19B 1.88B
Biogen BIIB:US USD 9.79B 25.4M
Brainstorm Cell Therapeutics BCLI:US USD 7.5M 5.3M
Cytokinetics CYTK:US USD 795.19M 89.09M
Cytrx CYTR:US USD 6.18M 2.1M
Daiichi Sankyo 4568:JP JPY 1.44T 19.68B
Gilead Sciences GILD:US USD 15.23B 1.67B
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Laboratory Of America LH:US USD 4.62B 253.2M
Myriad Genetics MYGN:US USD 274.6M 77.7M
Otsuka Holdings 4578:JP JPY 1.19T 11.62B
United Therapeutics UTHR:US USD 3.38B 323.9M